Monopar Therapeutics Inc MNPRNasdaq
116.35USDClose on 08/10
At a glance
Monopar Therapeutics Inc sits in the ‘Resting’ stage of its cycle. It has moved +256.2% since its first surge signal on 2024-10-24, when the past-year gain stood at +1298.7%.
- Since surge signal
- +256.2%
- First surge signal
- 2024-10-24
- Price at signal
- 32.66
- Past-year gain (at signal)
- +1298.7%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.